NPS Pharma to Report Third Quarter 2014 Financial Results
04 November 2014 - 12:10AM
Business Wire
NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced today that it
will report its third quarter 2014 financial results on Monday,
November 10, 2014 at approximately 4:00 p.m. ET. The press release
will be followed by a conference call and webcast at 4:30 p.m.
ET.
To participate in the conference call, dial (877) 576-3758.
International callers may dial +1 (443) 877-4073. In addition, a
live audio of the conference call will be available over the
Internet. Interested parties can access the event through the
investors’ calendar of events page on the NPS website at
http://ir.npsp.com/events.cfm.
If you are unable to participate in the live call, a replay will
be available at (855) 859-2056, with conference ID: 17738226 until
midnight ET, November 24, 2014. International callers may access
the replay by dialing +1 (404) 537-3406, using the same conference
ID. The webcast will also be available through the NPS website for
the same period.
About NPS Pharma
NPS Pharma is a global biopharmaceutical company pioneering and
delivering therapies that transform the lives of patients with rare
diseases. The company’s current therapeutic areas of focus are
gastrointestinal disease and endocrine disorders. These include
Short Bowel Syndrome, a potentially fatal gastrointestinal disorder
in which patients may have to rely on parenteral nutrition for
their survival; Hypoparathyroidism, a complex endocrine disorder in
which the parathyroid glands are either absent or damaged, and the
body produces insufficient or no parathyroid hormone; and Autosomal
Dominant Hypocalcemia, an ultra-rare, genetic disorder of calcium
homeostasis caused by mutations of the calcium-sensing receptor
gene. NPS Pharma continues to seek in-licensing opportunities to
develop new therapies for a broad range of rare diseases, and
complements its proprietary programs with a royalty-based portfolio
of products and product candidates that includes agreements with
Amgen, GlaxoSmithKline, Janssen Pharmaceuticals, and Kyowa Hakko
Kirin. NPS Pharma has operations in the U.S., Canada, Europe, Latin
America and Japan. Learn more at: www.npsp.com.
“NPS Pharma” and “NPS Pharmaceuticals” are the company's
trademarks.
NPS Pharmaceuticals, Inc.Gail Brophy, +
1-908-450-5335gbrophy@npsp.com
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Nps Pharmaceuticals, Inc. (MM) News Articles